Development was only the first step
As soon as the scale and seriousness of the COVID-19 pandemic became clear in early 2020, talk began to focus on the challenges of developing vaccines. The past year has seen an unprecedented effort to develop and deploy safe and effective vaccines to control a virus that has now claimed 2.5 million lives worldwide — and more than 500,000 in the U.S. alone.